Press releases
- Press releases
- Browse
Press releases
-- Breakthrough Chronotherapy Treatment for Hypertension Utilizes Eurand's Diffucaps® Technology -- More
New summary from Partneringdesk highlights trends in dealmaking from the top pharma and biotech companies More
Morphochem AG and Xenogen Corp. today announced that both companies have entered into a research collaboration to discover targets and develop compounds effective against bacterial biofilms. More
MARKETREADY(TM): a comprehensive, step-by-step process to help meet regulatory standards in pre-approval inspections. More
Scil Biomedicals - Innovative protein-based pharmaceutical products and medical devices More
Morphochem AG, has announced that one of its leading programmes, inhibitors of blood coagulation Factor Xa, led to the identification of novel, orally available anti-thrombotics in in preclinical studies More
Dragon Pharmaceuticals offers surplus stocks of recombinant EPO (erythropoietin) More
Study helps doctors give better care to patients More
More than 10,000 patients now involved in on-going studies of Crestor More
Morphochem enters into research collaboration with AstraZeneca AB (Sweden) - to apply MOREsystem(tm) drug discovery engine More
Related Reports
Market Research Reports provided by reports.iptechex.com
Nov 2010 - 40 pages - $500
Mar 2008 - 250 pages - $3,995
Nov 2010 - 20 pages - $125
Dec 2010 - 15 pages - $500
Jan 2010 - $75
Dec 2010 - 25 pages - $500
Dec 2010 - 16 pages - $500
Jul 2011 - 74 pages - $2,000
Feb 2011 - 17 pages - $125
Jul 2010 - 26 pages - $99
Your selection
Browse By
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us